Albert Einstein College of Medicine, Inc.;Adimab, LLC;MAPP BIOPHARMACEUTICAL, INC.
发明人:
Zachary A. Bornholdt,Larry Zeitlin,Kartik Chandran,Anna Wec,Laura Walker
申请号：
US16897027
公开号：
US20200299363A1
申请日:
2020.06.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
